Design, development and deployment of a web-based patient registry for rare genetic lipid disorders

Kathryn R Napier1, Amanda J Hooper2, David M Ng3

  • 1Centre for Comparative Genomics, Murdoch University, Murdoch, WA, Australia.

Pathology
|April 12, 2020
PubMed

Insights

A new web-based patient registry was developed for rare genetic lipid disorders to improve monitoring and research. This registry aims to enhance diagnosis, management, and treatment strategies for these complex conditions.

Area of Science:

  • Medical Genetics
  • Metabolic Disorders
  • Bioinformatics

Background:

  • Rare genetic lipid disorders are monogenic disorders of lipoprotein metabolism, excluding heterozygous familial hypercholesterolaemia (FH).
  • Patient registries are crucial for disease monitoring, clinical practice improvement, research facilitation, and therapeutic development.
  • Existing disease-specific registries for rare genetic lipid disorders are scarce.

Purpose of the Study:

  • To design, develop, and deploy a web-based patient registry for rare genetic lipid disorders.
  • To establish a platform for longitudinal data collection on 13 rare genetic lipid disorders, with future expandability.
  • To leverage the FH Australasia Network (FHAN) Registry model and the open-source Rare Disease Registry Framework (RDRF).

Main Methods:

  • Development of a web-based patient registry using the Rare Disease Registry Framework (RDRF).
  • Adaptation of the established FH Australasia Network (FHAN) Registry infrastructure.
  • Implementation of a system for capturing longitudinal data on multiple rare genetic lipid disorders.

Main Results:

  • Successful design, development, and deployment of the Rare Genetic Lipid Disorders Registry.
  • The registry is based on the RDRF, ensuring efficient customization and sustainable deployment.
  • The registry is capable of capturing longitudinal data for 13 specific rare genetic lipid disorders.

Conclusions:

  • The developed registry provides a critical tool for monitoring and research in rare genetic lipid disorders.
  • The web-based, adaptable framework allows for future expansion across Australia and internationally.
  • Data collected may significantly improve the diagnosis, management, and treatment of these rare conditions.